Pharmaceutical Coronavirus again dominated the news last week, as Germany’s CureVac gained a lot of attention on talk that the US government was planning to acquire its COVID-10 program. Another German company, BioNTech, announced solid progress on its COVID-19 vaccine program along with a new alliance with Fosun Pharma. US biotech Moderna shot up on Monday, on news that its coronavirus vaccine mRNA-1273 had seen its first patient dosed in a National Institutes of Health study. There was also a fair amount of excitement after Chinese doctors declared that Fujifilm Toyama’s Avigan was effective in COVID-19. Meantime, Novo Nordisk suffered a setback in a trial of concizumab in hemophilia. 22 March 2020